30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Biotechnology & Medical Research

Antibe Therapeutics Inc (ATE)

Track

Stock chart
Ticker: ATE Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Legault, Daniel Marcel
Director of Issuer, Director or Senior Officer of 10% Security Holder, Senior Officer of Issuer
1 purchase — total 10,000 CAD
Buy 7 Mar 2024
Value CA$4,810,090.37 | Price 63.65 | Shares 12,746
Buy 7 Mar 2024
Value CA$2,643,174.61 | Price 147.30 | Shares 40,524
Buy 6 Mar 2024
Value US$9,600.00 | Price 0.40 | Shares 24,000
Sale 13 Dec 2022
Value CA$44,590.00 | Price 0.49 | Shares 91,000
Sale 12 Dec 2022
Value CA$77,910.00 | Price 0.49 | Shares 159,000
Buy 16 Nov 2022
Value US$4,897.86 | Price 0.36 | Shares 13,530
Buy 15 Nov 2022
Value CA$19,400.00 | Price 0.49 | Shares 40,000
Buy 15 Nov 2022
Value CA$10,000.00 | Price 0.50 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-07 2024-03-07 B Purchase
2.6
Legault, Daniel Marcel

Director of Issuer, Director or Senior Officer of 10% Security Holder, Senior Officer of Issuer

Executive Director
12,746 +18.4%
63.65
CA$4,810,090 		12,746 +18.4% 63.65 CA$4,810,090
2024-03-07 2024-03-07 B Purchase
2.5
Curtis, Scott Wilson

Senior Officer of Issuer

Officer
40,524 +39.7%
147.30
CA$2,643,175 		40,524 +39.7% 147.30 CA$2,643,175
2024-03-06 2024-03-06 B Purchase
2.4
Stauffer, Joseph

Senior Officer of Issuer

Officer
11,964 +43.2%
467.26
US$4,491,734 		11,964 +43.2% 467.26 US$4,491,734
2022-12-16 2022-12-13 S Sale
1.6
Wallace, John Lawrence

Director of Issuer, Director or Senior Officer of 10% Security Holder, Senior Officer of Issuer

Executive Director
91,000 -5.6%
0.49
CA$44,590 		91,000 -5.6% 0.49 CA$44,590
2022-12-16 2022-12-12 S Sale
1.6
Wallace, John Lawrence

Director of Issuer, Director or Senior Officer of 10% Security Holder, Senior Officer of Issuer

Executive Director
159,000 -9.0%
0.49
CA$77,910 		159,000 -9.0% 0.49 CA$77,910
2022-11-16 2022-11-16 B Purchase
2.4
Stauffer, Joseph

Senior Officer of Issuer

Officer
13,530 +10.6%
0.36
US$4,898 		13,530 +10.6% 0.36 US$4,898
2022-11-16 2022-11-15 B Purchase
2.6
Legault, Daniel Marcel

Senior Officer of Issuer

Officer
40,000 +4.2%
0.49
CA$19,400 		40,000 +4.2% 0.49 CA$19,400
2022-11-16 2022-11-15 B Purchase
2.5
Curtis, Scott Wilson

Senior Officer of Issuer

Officer
20,000 +25.0%
0.50
CA$10,000 		20,000 +25.0% 0.50 CA$10,000
Explore more

More insider trading research around Antibe Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America